Concepedia

Andrea Iskenderian

AI

Statistics

Publications

3

Citations

95

H-Index

3

Active since

2010

Affiliations

Takeda (United States)(Current)

Andrea Iskenderian is an author at Takeda (United States) specializing in medicine, myostatin signaling, and tumor microenvironment.

Publications per year

2010–2018

3

Publications

3

Myostatin and activin blockade by engineered follistatin results in hypertrophy and improves dystrophic pathology in mdx mouse more than myostatin blockade alone

Andrea Iskenderian, Nan Liu, Qingwei Deng et al. · Skeletal Muscle · 2018 · 48 citations · Full text

Medicine, Cell Biology, Pharmacotherapy +16

Human Sulfatase 2 inhibits in vivo tumor growth of MDA-MB-231 human breast cancer xenografts

Sarah Peterson, Andrea Iskenderian, Lynette Cook et al. · BMC Cancer · 2010 · 33 citations · Full text

Medicine, Biochemistry, Oncology +17

Protein Engineering on Human Recombinant Follistatin: Enhancing Pharmacokinetic Characteristics for Therapeutic Application

Chuan Shen, Andrea Iskenderian, Dianna Lundberg et al. · Journal of Pharmacology and Experimental Therapeutics · 2018 · 14 citations · Full text

Engineering, Biotechnology, Pharmaceutical Biotechnology +14

1–3 of 3